The United States has recorded 4,588 confirmed measles cases in 2026, up 178 in one week and more than double the 2,289 reported during all of 2025, according to federal data updated Friday.
The latest CDC tally, current through noon Thursday, also shows 479 hospitalizations and 43 outbreaks this year. Children and teenagers ages 5 through 19 account for 1,914 cases, or 42 percent, while adults 20 and older account for 1,881, or 41 percent. The national increase and age distribution were independently reported by Reuters.
The totals describe a sustained national public-health problem rather than a single isolated cluster. Ninety-six percent of confirmed cases are associated with outbreaks, including transmission chains that began in both 2025 and 2026. The reported count is also provisional: the CDC includes only confirmed cases that jurisdictions have notified to the agency, so it does not measure every infection or every probable case.
The central evidence is unusually consistent on prevention. National vaccination coverage among kindergartners has fallen below the level generally needed for community protection, and the largest current state outbreak is overwhelmingly concentrated among people who were not vaccinated. The harder question is whether public-health systems can reach those communities quickly enough while maintaining reliable, transparent surveillance.
Transmission Remains Broad and Persistent
The weekly curve shows that transmission has continued through the school year rather than fading after a short seasonal peak. The CDC recorded 206 cases with rash onset in the week beginning September 27, 179 the week beginning October 4 and 116 the week beginning October 11. The most recent week is incomplete because diagnosis, confirmation and reporting occur after symptoms begin, making the 28 cases currently assigned to the week of October 18 an unreliable measure of the final total.
That reporting lag matters when interpreting the 178-case week-over-week rise. It reflects newly reported confirmed cases, not necessarily infections acquired during those seven days. Measles symptoms generally begin one to three weeks after exposure, and people can spread the virus before the characteristic rash appears. Public-health officials therefore respond to known exposures and local clusters rather than waiting for the national curve to settle.
The national case count is nearly four times the 1,274 cases recorded in 2019, the previous post-elimination high listed on the CDC dashboard. Still, it remains far below the pre-vaccine era, when the agency estimates 3 million to 4 million Americans were infected annually. That historical comparison does not make the current resurgence minor: modern case counts occur in a population with widespread vaccine protection, so thousands of cases signal substantial pockets of susceptibility.
Pennsylvania Shows the Clinical Burden
Pennsylvania reported 1,338 confirmed cases across 44 counties as of Friday, representing roughly 29 percent of the national total. The state’s health department reported 255 hospitalizations and five confirmed measles-associated deaths. It also said only four cases, fewer than 1 percent of the state total, occurred among vaccinated people. Reuters separately reported the same state totals in its national update.
The hospitalization burden is consistent with the known severity of measles in susceptible populations. The CDC’s clinical summary estimates that about one in five unvaccinated U.S. patients is hospitalized. Pneumonia occurs in as many as one in 20 infected children, and encephalitis in about one in 1,000. Young children, adults older than 20, pregnant people and those with weakened immune systems face higher complication risks.
Pennsylvania’s response illustrates the labor required once transmission becomes established. About 300 state health employees are involved in outreach, clinical coordination and case response. State staff have administered more than 6,500 MMR doses through 226 pop-up clinics since the outbreak began in late April, while total doses delivered by state nurses in 2026 exceed 10,300. Private-provider demand also rose: the state reported more than 56,000 MMR doses administered in September, compared with about 25,000 in a typical month.
Those figures show activity, not yet proof that transmission has been interrupted. Vaccination campaigns protect people who develop immunity, but the effect on an outbreak depends on where doses are delivered, who accepts them and how quickly coverage rises within the networks where exposure is occurring. Pennsylvania added 21 cases and two counties between its October 21 and October 23 updates, indicating that the response has not yet stopped spread.
Falling Coverage Created More Openings
National MMR coverage among kindergartners fell from 95.2 percent in the 2019–2020 school year to 92.4 percent in 2025–2026. CDC school data estimate that about 280,000 kindergartners attended without documentation of completing the MMR series. Exemptions from one or more vaccines rose to 4.2 percent from 3.6 percent in one year, with increases in 41 states and the District of Columbia.
A national average can obscure greater local vulnerability. Communities with coverage below the national level may sustain transmission even when a state’s overall rate appears relatively high. Measles is sufficiently contagious that public-health agencies generally use coverage above 95 percent as the community-immunity benchmark. The current outbreak pattern is therefore better understood as clustered immunity gaps than as evidence that vaccination has broadly failed.
The vaccine evidence points in the same direction. CDC vaccine guidance estimates one MMR dose is 93 percent effective against measles and two doses are 97 percent effective. Breakthrough infections can occur, particularly after prolonged or intense exposure, but Pennsylvania’s four vaccinated cases among 1,338 confirmed infections are consistent with most disease occurring among people without documented protection.
Coverage estimates have limits. School surveys differ by state, some rely on voluntary responses, and kindergarten data do not describe immunity across every age group. Case vaccination status can also be incomplete or difficult to verify. Even so, declining school coverage, rising exemptions and the concentration of cases among unvaccinated people form a coherent explanation for why imported measles can now spread through multiple communities.
Two Death Counts Expose a Surveillance Gap
The CDC reports three measles deaths nationally in 2026, while Pennsylvania has confirmed five in that state alone. The difference does not mean either agency has necessarily counted the same deaths incorrectly. Federal officials switched to National Center for Health Statistics mortality data, which depend on death-certificate review, while states can classify deaths through their own epidemiologic investigations on a different timetable.
That methodological change has reduced the detail available to the public. A separate Reuters report said the CDC would not identify the states associated with its three deaths and noted the gap with Pennsylvania’s count. Independent reporting found that former federal officials and health-law specialists questioned whether privacy rules prevent disclosure at the state level.
For outbreak management, the exact timing and location of severe outcomes matter because they shape risk communication, clinical preparedness and public trust. Mortality data often take longer to finalize than case surveillance, but unexplained differences invite confusion when the outbreak is expanding. A transparent reconciliation should specify which deaths are confirmed, which remain under review and why state and federal systems use different definitions or reporting clocks.
The Next Test Is Local Immunity
New York’s health department has also declared a disaster emergency in response to rising measles rates, according to its official state update. The spread into multiple jurisdictions means the national response cannot depend on one state containing one cluster. Rapid diagnosis, isolation, contact tracing and accessible vaccination all remain necessary because an infected traveler can introduce the virus wherever immunity gaps exist.
The United States declared measles eliminated in 2000, meaning continuous domestic transmission had been absent for at least 12 months. The CDC’s clinical overview notes that outbreaks still occur when measles is brought from places where the virus circulates. A large annual total alone does not establish that elimination status has been lost; investigators must determine whether a single chain has continued for a year.
The near-term indicators are more concrete. Health officials will watch whether weekly rash-onset counts decline after reporting delays are resolved, whether hospitalization growth slows, whether the Pennsylvania outbreak reaches fewer new counties and whether vaccination rises in the communities experiencing transmission. Until those measures improve together, the 4,588-case total should be read as evidence that national vaccine coverage averages are no longer sufficient to protect every local population.